Overlap of Post-obstructive Diuresis and Unmasked Diabetes Insipidus in a Case of IgG4-related Retroperitoneal Fibrosis and Tuberoinfundibular Hypophysitis: A Case Report and Review of the Literature.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28049999)

Published in Intern Med on January 01, 2017

Authors

Midori Sasaki Yatabe1, Kimio Watanabe, Yoshimitsu Hayashi, Junichi Yatabe, Satoshi Morimoto, Atsuhiro Ichihara, Masaaki Nakayama, Tsuyoshi Watanabe

Author Affiliations

1: Department of Nephrology, Hypertension, Diabetology, Crinology and Metabolism, Fukushima Medical University School of Medicine, Japan.

Articles cited by this

High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med (2001) 12.49

Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol (2012) 7.39

A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol (2011) 4.26

IgG4-related disease. Lancet (2014) 3.04

Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis (2015) 2.83

The clinical spectrum of IgG4-related disease. Autoimmun Rev (2014) 2.10

IgG4-related hypophysitis: a new addition to the hypophysitis spectrum. J Clin Endocrinol Metab (2011) 1.58

Transient lymphocytic panhypophysitis associated with SIADH leading to diabetes insipidus after glucocorticoid replacement. Intern Med (2003) 1.54

Hypophysitis presented as inflammatory pseudotumor in immunoglobulin G4-related systemic disease. Hum Pathol (2007) 1.38

Development of an IgG4-RD Responder Index. Int J Rheumatol (2012) 1.20

Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity. Endocr J (2009) 1.16

Retroperitoneal fibrosis associated with immunoglobulin G4-related disease. World J Gastroenterol (2013) 1.02

The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and/or central diabetes insipidus and review of the literature. Eur J Endocrinol (2013) 1.02

Immunology of IgG4-related disease. Clin Exp Immunol (2015) 1.00

Long-term clinical course of IgG4-related systemic disease accompanied by hypophysitis. Endocr J (2010) 0.97

Severe post-renal acute kidney injury, post-obstructive diuresis and renal recovery. BJU Int (2012) 0.93

Occurrence of IgG4-related hypophysitis lacking IgG4-bearing plasma cell infiltration during steroid therapy. Intern Med (2012) 0.91

Prednisolone markedly reduced serum IgG4 levels along with the improvement of pituitary mass and anterior pituitary function in a patient with IgG4-related infundibulo-hypophysitis. Endocr J (2013) 0.88

IgG4-Related Disease without Overexpression of IgG4: Pathogenesis Implications. Case Rep Rheumatol (2012) 0.83

[A case of IgG4-related disease with deterioration in pulmonary and pituitary involvements during a 10-year clinical course of inflammatory pseudotumor]. Nihon Kokyuki Gakkai Zasshi (2011) 0.83

Rapid conversion of autoimmune hypophysitis to an empty sella with immediate lowering of the serum IgG4 level. Case Report. Neuro Endocrinol Lett (2015) 0.80

Articles by these authors

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Mini nutritional assessment as a useful method of predicting the development of pressure ulcers in elderly inpatients. J Am Geriatr Soc (2013) 2.70

Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol (2009) 2.66

Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol (2007) 2.58

Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis (2010) 2.47

Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol (2007) 2.20

Prorenin receptor is essential for normal podocyte structure and function. J Am Soc Nephrol (2011) 2.08

Regression of nephropathy developed in diabetes by (Pro)renin receptor blockade. J Am Soc Nephrol (2007) 2.04

Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol (2012) 1.95

Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats. J Am Soc Nephrol (2007) 1.87

Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures. Perit Dial Int (2005) 1.78

Association between prehypertension and chronic kidney disease in the Japanese general population. Kidney Int (2011) 1.76

The (pro)renin receptor/ATP6AP2 is essential for vacuolar H+-ATPase assembly in murine cardiomyocytes. Circ Res (2010) 1.76

Risk factors for bleeding complications in percutaneous renal biopsy. Clin Exp Nephrol (2005) 1.75

Circadian clock gene regulation of steroidogenic acute regulatory protein gene expression in preovulatory ovarian follicles. Endocrinology (2007) 1.74

SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation. J Am Soc Nephrol (2009) 1.70

Local production of angiotensin II in the subfornical organ causes elevated drinking. J Clin Invest (2007) 1.56

Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin Chem (2006) 1.51

Body Mass Index Modifies an Association between Self-Reported Regular Exercise and Proteinuria. J Atheroscler Thromb (2015) 1.45

MicroRNA signatures in Helicobacter pylori-infected gastric mucosa. Int J Cancer (2010) 1.44

New-onset hypertension and risk for chronic kidney disease in the Japanese general population. J Hypertens (2014) 1.43

Prediction of pregnancy-induced hypertension by a shift of blood pressure class according to the JSH 2009 guidelines. Hypertens Res (2011) 1.43

Helicobacter pylori vacuolating cytotoxin induces activation of the proapoptotic proteins Bax and Bak, leading to cytochrome c release and cell death, independent of vacuolation. J Biol Chem (2006) 1.43

Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology. Clin J Am Soc Nephrol (2008) 1.41

Acute changes in home blood pressure after the Great East Japan Earthquake among patients with chronic kidney disease in Fukushima City. Clin Exp Nephrol (2012) 1.40

Fabry disease with few clinical signs and symptoms. Intern Med (2002) 1.40

Involvement of activated prorenin in the pathogenesis of slowly progressive nephropathy in the non-clipped kidney of two kidney, one-clip hypertension. Hypertens Res (2010) 1.39

Use of a proton-pump inhibitor for metabolic disturbances associated with anorexia nervosa. N Engl J Med (2002) 1.39

Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function. Clin Exp Nephrol (2010) 1.39

Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods. Hypertens Res (2008) 1.39

GFR estimation using standardized serum cystatin C in Japan. Am J Kidney Dis (2012) 1.36

Metabolomic profiling of uremic solutes in CKD patients. Hypertens Res (2010) 1.26

(Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation. Diabetes (2009) 1.24

Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapy. Clin Exp Nephrol (2009) 1.23

Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression. Hypertension (2006) 1.22

(Pro)renin receptor-mediated activation of mitogen-activated protein kinases in human vascular smooth muscle cells. Hypertens Res (2007) 1.21

Interaction of alpha1-adrenoceptor subtypes with different G proteins induces opposite effects on cardiac L-type Ca2+ channel. Circ Res (2008) 1.21

Prevalence and incidence of chronic kidney disease stage G5 in Japan. Clin Exp Nephrol (2014) 1.20

Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney Int (2004) 1.18

Reorganization of the suprachiasmatic nucleus coding for day length. J Biol Rhythms (2008) 1.17

Changes in cerebral and autonomic activity heralding periodic limb movements in sleep. Sleep Med (2004) 1.17

Common variation in GPC5 is associated with acquired nephrotic syndrome. Nat Genet (2011) 1.17

Design and methods of a strategic outcome study for chronic kidney disease: Frontier of Renal Outcome Modifications in Japan. Clin Exp Nephrol (2009) 1.15

Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin. Invest Ophthalmol Vis Sci (2006) 1.14

Protein-tyrosine phosphatase alpha, RPTP alpha, is a Helicobacter pylori VacA receptor. J Biol Chem (2003) 1.14

Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy. Am J Kidney Dis (2005) 1.11

The gene controlling marijuana psychoactivity: molecular cloning and heterologous expression of Delta1-tetrahydrocannabinolic acid synthase from Cannabis sativa L. J Biol Chem (2004) 1.11

Salt sensitivity is associated with insulin resistance, sympathetic overactivity, and decreased suppression of circulating renin activity in lean patients with essential hypertension. Am J Clin Nutr (2010) 1.11

Molecular characterization of Helicobacter pylori VacA induction of IL-8 in U937 cells reveals a prominent role for p38MAPK in activating transcription factor-2, cAMP response element binding protein, and NF-kappaB activation. J Immunol (2008) 1.10

Type 2 iodothyronine deiodinase is expressed in human preadipocytes. Thyroid (2011) 1.10

Femoral nerve palsy associated with iliacus hematoma following pseudoaneurysm after revision hip arthroplasty. J Arthroplasty (2008) 1.09

Mutation screening of the human Clock gene in circadian rhythm sleep disorders. Psychiatry Res (2002) 1.09

Methylglyoxal is a predictor in type 2 diabetic patients of intima-media thickening and elevation of blood pressure. Hypertension (2010) 1.09

Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis. Am J Nephrol (2007) 1.08

A missense variation in human casein kinase I epsilon gene that induces functional alteration and shows an inverse association with circadian rhythm sleep disorders. Neuropsychopharmacology (2004) 1.07

Cannabidiolic-acid synthase, the chemotype-determining enzyme in the fiber-type Cannabis sativa. FEBS Lett (2007) 1.06

Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux. Br J Pharmacol (2004) 1.06

Photoperiodic regulation of type 2 deiodinase gene in Djungarian hamster: possible homologies between avian and mammalian photoperiodic regulation of reproduction. Endocrinology (2004) 1.05

Significance of screening for Fabry disease among male dialysis patients. Clin Exp Nephrol (2005) 1.05

Anti-colitis and -adhesion effects of daikenchuto via endogenous adrenomedullin enhancement in Crohn's disease mouse model. J Crohns Colitis (2009) 1.05

Past daily light cycle recorded in the strontium/calcium ratios of giant clam shells. Nat Commun (2012) 1.03

Gangliosides act as co-receptors for Salmonella enteritidis FliC and promote FliC induction of human beta-defensin-2 expression in Caco-2 cells. J Biol Chem (2004) 1.03

Clinical correlates of ambulatory BP monitoring among patients with CKD. Clin J Am Soc Nephrol (2013) 1.03

Aliskiren inhibits intracellular angiotensin II levels without affecting (pro)renin receptor signals in human podocytes. Am J Hypertens (2010) 1.03

Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD. Clin J Am Soc Nephrol (2014) 1.01

A randomized trial of JTT-751 versus sevelamer hydrochloride in patients on hemodialysis. Nephrol Dial Transplant (2013) 1.01

Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization. Invest Ophthalmol Vis Sci (2007) 1.00

Secretogranin III binds to cholesterol in the secretory granule membrane as an adapter for chromogranin A. J Biol Chem (2003) 1.00

Expression of CD109 in human cancer. Oncogene (2004) 1.00

Neuron-specific (pro)renin receptor knockout prevents the development of salt-sensitive hypertension. Hypertension (2013) 1.00

Management of anemia in chronic kidney disease patients: baseline findings from Chronic Kidney Disease Japan Cohort Study. Clin Exp Nephrol (2011) 0.99

Interaction between secretogranin III and carboxypeptidase E facilitates prohormone sorting within secretory granules. J Cell Sci (2005) 0.99

Impact of body mass index on clinical outcome in patients hospitalized with congestive heart failure. Circ J (2011) 0.99

Deletion of the prorenin receptor from the ureteric bud causes renal hypodysplasia. PLoS One (2013) 0.98

The psychological aspects of patients with delayed sleep phase syndrome (DSPS). Sleep Med (2003) 0.98

Methylglyoxal contributes to the development of insulin resistance and salt sensitivity in Sprague-Dawley rats. J Hypertens (2009) 0.97

Skin autofluorescence is associated with renal function and cardiovascular diseases in pre-dialysis chronic kidney disease patients. Nephrol Dial Transplant (2010) 0.97

Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease. Clin Exp Nephrol (2013) 0.97

Cost-effectiveness of chronic kidney disease mass screening test in Japan. Clin Exp Nephrol (2011) 0.97

Dopamine and angiotensin type 2 receptors cooperatively inhibit sodium transport in human renal proximal tubule cells. Hypertension (2012) 0.97

Identification of a mouse cytoskeleton-associated protein, CKAP2, with microtubule-stabilizing properties. Cancer Sci (2004) 0.96

Performance of serum cystatin C versus serum creatinine as a marker of glomerular filtration rate as measured by inulin renal clearance. Clin Exp Nephrol (2011) 0.96

Identification of a chromogranin A domain that mediates binding to secretogranin III and targeting to secretory granules in pituitary cells and pancreatic beta-cells. Mol Biol Cell (2002) 0.96

Carbonyl stress induces hypertension and cardio-renal vascular injury in Dahl salt-sensitive rats. Hypertens Res (2013) 0.96

Tetrahydrocannabinolic acid synthase, the enzyme controlling marijuana psychoactivity, is secreted into the storage cavity of the glandular trichomes. Plant Cell Physiol (2005) 0.95

Angiotensin III stimulates aldosterone secretion from adrenal gland partially via angiotensin II type 2 receptor but not angiotensin II type 1 receptor. Endocrinology (2011) 0.95

Prorenin induces vascular smooth muscle cell proliferation and hypertrophy via epidermal growth factor receptor-mediated extracellular signal-regulated kinase and Akt activation pathway. J Hypertens (2011) 0.95

Daikenchuto (TU-100) ameliorates colon microvascular dysfunction via endogenous adrenomedullin in Crohn's disease rat model. J Gastroenterol (2011) 0.95

Helicobacter pylori VacA reduces the cellular expression of STAT3 and pro-survival Bcl-2 family proteins, Bcl-2 and Bcl-XL, leading to apoptosis in gastric epithelial cells. Dig Dis Sci (2010) 0.95

Soluble (pro)renin receptor and blood pressure during pregnancy: a prospective cohort study. Hypertension (2012) 0.94

Risk factor profiles based on estimated glomerular filtration rate and dipstick proteinuria among participants of the Specific Health Check and Guidance System in Japan 2008. Clin Exp Nephrol (2011) 0.94

Plasma alpha-oxoaldehyde levels in diabetic and nondiabetic chronic kidney disease patients. Am J Nephrol (2008) 0.94